Literature DB >> 22140079

Comparative hepatic proteome analysis between lean and obese rats fed a high-fat diet reveals the existence of gender differences.

Xia Wang1, Jung-Won Choi, Tae Seok Oh, Duk Kwon Choi, Rajib Mukherjee, Hao Liu, Jong Won Yun.   

Abstract

Gender differences in obesity stem from metabolic and hormonal differences between sexes and contribute to differences between women and men in health risks attributable to obesity. We hypothesized that liver may be an ideal target for the evaluation of gender differences in obesity development in response to a high-fat diet (HFD). Therefore, to test this hypothesis, we performed a global proteome analysis in the liver of lean and obese rats of both genders who were fed an HFD through 2-DE combined with MALDI-TOF-MS. When rats were exposed to HFD, male rats gained more body weight with increased values of plasma biochemical parameters than female rats. Image analysis and further statistical analysis of a 2-DE protein map allowed for the detection and identification of 34 proteins that were significantly modulated in a gender-dependent manner. We found 19 proteins showing identical gender-different regulation in both normal diet (ND) and HFD. Five proteins also showed clear gender differences in both ND and HFD; however, their regulation modes in HFD were opposite to those in ND. Of particular interest, 10 proteins showed gender differences only in either ND or HFD rats. Present proteomic insight into gender-dimorphic protein modulation in liver would aid in the improvement of gender awareness in the health-care system and in implementation of evidence-based gender-specific clinical recommendations.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22140079     DOI: 10.1002/pmic.201100271

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  7 in total

1.  Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier.

Authors:  Suidong Ouyang; Hung Hsuchou; Abba J Kastin; Yuping Wang; Chuanhui Yu; Weihong Pan
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-25       Impact factor: 6.200

2.  Effect of estrogen on expression of prohibitin in white adipose tissue and liver of diet-induced obese rats.

Authors:  Minji Choi; Harmesh N Chaudhari; Young Rae Ji; Zae Young Ryoo; Sang Woo Kim; Jong Won Yun
Journal:  Mol Cell Biochem       Date:  2015-06-06       Impact factor: 3.396

3.  Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis.

Authors:  Sompop Bencharit; Sarah Schwartz Baxter; Jim Carlson; Warren C Byrd; Mary Virginia Mayo; Michael B Border; Heidi Kohltfarber; Eugene Urrutia; Escher L Howard-Williams; Steven Offenbacher; Michael C Wu; John B Buse
Journal:  Mol Biosyst       Date:  2013-11

4.  Proteomic Identification of Target Proteins of Thiodigalactoside in White Adipose Tissue from Diet-Induced Obese Rats.

Authors:  Hilal Ahmad Parray; Jong Won Yun
Journal:  Int J Mol Sci       Date:  2015-06-25       Impact factor: 5.923

5.  Sex-dependent expression of caveolin 1 in response to sex steroid hormones is closely associated with development of obesity in rats.

Authors:  Rajib Mukherjee; Sang Woo Kim; Myung Sook Choi; Jong Won Yun
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

6.  Gender specific differences in the liver proteome of rats exposed to short term and low-concentration hexabromocyclododecane (HBCD).

Authors:  I Miller; C Diepenbroek; E Rijntjes; J Renaut; K J Teerds; C Kwadijk; S Cambier; A J Murk; A C Gutleb; T Serchi
Journal:  Toxicol Res (Camb)       Date:  2016-06-30       Impact factor: 3.524

7.  Differential representation of liver proteins in obese human subjects suggests novel biomarkers and promising targets for drug development in obesity.

Authors:  Simonetta Caira; Antonio Iannelli; Rosaria Sciarrillo; Gianluca Picariello; Giovanni Renzone; Andrea Scaloni; Pietro Addeo
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.